Tag: sanofi
-
Regeneron CEO says Amgen not putting patients first in patent dispute
A federal judge last week handed Regeneron and its partner Sanofi a stunning setback by banning sales of their LDL-lowering medicine Praluent, finding it infringed patents held by Amgen on its Repatha cholesterol drug. Regeneron and Sanofi were given 30 days before the ban takes effect to give them time to appeal.
-
California Republican challenges state’s hiring of Eric Holder to fight Trump policies
By Sharon Bernstein SACRAMENTO, Calif. (Reuters) – A California Republican state lawmaker is challenging the legality of a move by Democrats in the legislature to hire former U.S. Attorney General Eric Holder to help in any legal battles with President-elect Donald Trump's administration. Assembly member Kevin Kiley has requested a formal ruling from state lawyers…
-
Watchdog urges greater protection of UK transgender prisoners as deaths climb
By Lin Taylor LONDON (Thomson Reuters Foundation) – Transgender prisoners in Britain need more support and greater protection from bullying and harassment, a government watchdog said on Tuesday, more than a week after a transgender woman was found dead in her cell. Transgender prisoners are especially vulnerable to discrimination and sexual violence, and they have…
-
Drugmakers under fire for possible U.S. price fixing
The request by U.S. Senator Bernie Sanders and Representative Elijah Cummings follows a similar letter they sent last fall calling for an investigation into 14 drug companies over price increases of generic drugs. U.S. prosecutors could file the first charges by the end of the year in their subsequent criminal investigation of generic drugmakers over…
-
Drugmakers under fire for possible U.S. price fixing
The request by U.S. Senator Bernie Sanders and Representative Elijah Cummings follows a similar letter they sent last fall calling for an investigation into 14 drug companies over price increases of generic drugs. U.S. prosecutors could file the first charges by the end of the year in their subsequent criminal investigation of generic drugmakers over…
-
More U.S. middle school students dying of suicide than car crashes
The steady seven-year rise in middle school suicides, from an annual rate of 0.9 to 2.1 per 100,000, came as traffic deaths among the same age group declined to 1.9 per 100,000, according to the Centers for Disease Control and Prevention in Atlanta. In aggregate numbers, 425 young people 10 to 14 years of age…
-
Sanofi ready to up offer for drugmaker Medivation, could oust board
PARIS/NEW YORK (Reuters) – France's Sanofi said it could raise its proposed $9.3 billion deal to buy Medivation if the U.S. cancer drugmaker engaged in talks, threatening to go directly to shareholders to oust the board if not. Sanofi Chief Executive Olivier Brandicourt wrote in a letter to the board of Medivation published on Thursday…